Recent Analysts’ Ratings Updates for Tarsus Pharmaceuticals (TARS)
Several brokerages have updated their recommendations and price targets on shares of Tarsus Pharmaceuticals (NASDAQ: TARS) in the last few weeks: 9/24/2026 – Tarsus Pharmaceuticals is now covered by The Goldman Sachs Group, Inc.. They set a “buy” rating and a $116.00 price target on the stock. 9/24/2026 – Tarsus Pharmaceuticals had its “buy” rating […]
2 Oct 18:56 · The Markets Daily